Archive: 2026/02 - Page 2

How Buyers Leverage Generic Competition to Negotiate Lower Drug Prices

Posted By John Morris    On 4 Feb 2026    Comments (9)

How Buyers Leverage Generic Competition to Negotiate Lower Drug Prices

Generic drugs drive massive savings through competition, but buyers must strategically leverage this to negotiate better prices. This article explains real-world tactics used by governments and insurers, challenges like reverse payments, and future trends shaping drug pricing.

READ MORE
Foreign Manufacturing of Generics: FDA Oversight and Standards in 2026

Posted By John Morris    On 3 Feb 2026    Comments (9)

Foreign Manufacturing of Generics: FDA Oversight and Standards in 2026

The FDA now conducts unannounced inspections of foreign drug factories making generics for the U.S. market. With 80% of active ingredients coming from India and China, stricter oversight is reducing contamination, falsified records, and safety risks. What this means for patients.

READ MORE
Spondylolisthesis: Understanding Back Pain, Instability, and When Fusion Might Help

Posted By John Morris    On 2 Feb 2026    Comments (14)

Spondylolisthesis: Understanding Back Pain, Instability, and When Fusion Might Help

Spondylolisthesis causes lower back pain and instability when a spine bone slips forward. Most cases improve with physical therapy, but fusion surgery may be needed for severe or persistent symptoms. Learn about causes, symptoms, and when fusion works best.

READ MORE
Pituitary Adenomas: Understanding Prolactinomas and Hormone Imbalances

Posted By John Morris    On 1 Feb 2026    Comments (10)

Pituitary Adenomas: Understanding Prolactinomas and Hormone Imbalances

Prolactinomas are the most common type of pituitary tumor, causing hormone imbalances that affect fertility, sex drive, and vision. Learn how dopamine agonists like cabergoline treat them effectively - and when surgery or radiation may be needed.

READ MORE